Sherry Ci
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 5
- Cancer Treatment and Pharmacology 5
-
- Protein purification and stability 1
- Heat shock proteins research 1
- Co-authors
- Neil Desai (7 shared papers)Andrew Yang (6 shared papers)Patrick Soon‐Shiong (3 shared papers)Vuong Trieu (5 shared papers)Leslie Louie (5 shared papers)Tapas De (4 shared papers)Donald J. Dykes (1 shared paper)Michael Hawkins (2 shared papers)
- Journals
- Cancer Research (4 papers)Clinical Cancer Research (1 paper)Journal of Chromatography A (1 paper)Cell Biochemistry and Biophysics (1 paper)
- Partner nations
- China
In The Last Decade
Sherry Ci
7 papers receiving 957 citations
Sherry Ci's Hit Papers
Peers
Comparison fields: 5 of 92
- Biomaterials 354
- Oncology 356
- Pharmaceutical Science 61
- Cancer Research 82
- Biomedical Engineering 192
Countries citing papers authored by Sherry Ci
This map shows the geographic impact of Sherry Ci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Ci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Ci more than expected).
Fields of papers citing papers by Sherry Ci
This network shows the impact of papers produced by Sherry Ci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Ci. The network helps show where Sherry Ci may publish in the future.
Co-authors
The 15 scholars most cited alongside Sherry Ci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Hit paper breakdown → | 2006 | 909 |
| 2 | 1999 | 46 | |
| 3 | Enhanced efficacy and safety of nanoparticle albumin-bound nab-docetaxel versus taxotere. | 2006 | 9 |
| 4 | Characterization and in vitro/in vivo dissolution of nab-paclitaxel nanoparticles | 2008 | 7 |
| 5 | Comparison of physicochemical characteristics and stability of three novel formulations of paclitaxel: Abraxane, Nanoxel, and Genexol PM | 2008 | 5 |
| 6 | Nanoparticle albumin-bound (nab) rapamycin as an anticancer agent | 2007 | 5 |
| 7 | Pharmacokinetic and ADME study of nanoparticle albumin-bound 17AAG (nab-17AAG) in mice | 2008 | 2 |
| 8 | 2025 | 0 |
About Sherry Ci
Sherry Ci is a scholar working on Oncology, Molecular Biology, Biomaterials, Cancer Research and Pharmacology, having authored 8 papers that have together received 983 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Nanoparticle-Based Drug Delivery (2 papers), Protein purification and stability (1 paper), Heat shock proteins research (1 paper), Microtubule and mitosis dynamics (1 paper), Medical Imaging and Analysis (1 paper), Seaweed-derived Bioactive Compounds (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Biomaterials (354 citations), Oncology (356 citations), Pharmaceutical Science (61 citations), Cancer Research (82 citations) and Biomedical Engineering (192 citations). Sherry Ci has collaborated with scholars based in China. Frequent co-authors include Neil Desai, Andrew Yang, Patrick Soon‐Shiong, Vuong Trieu, Leslie Louie, Tapas De, Donald J. Dykes, Michael Hawkins, Zhiwen Yao and Patricia E. Noker. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Journal of Chromatography A and Cell Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.